Medtronic Spinal and Biologics
Clinical trials sponsored by Medtronic Spinal and Biologics, explained in plain language.
A division of Medtronic focused on spinal and biologic products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bone graft study aims to improve spine surgery outcomes Results expected Jul 2027 (estimated)
-
New spine cage aims to improve back surgery outcomes
Disease control Recruiting nowThis study compares a new spine cage device (MDT-0123) to a standard bone graft for patients needing two-level spinal fusion in the lower back. About 140 adults with disc degeneration or spinal deformity will be enrolled in Japan. The main goal is to see if the device leads to be…
Phase 3 • Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Massive spine device registry launches to see how medtronic tools perform in real surgeries
Knowledge-focused Recruiting nowThis study will follow 1,000 people receiving Medtronic spinal or cranial devices during routine surgery. Researchers will track outcomes like fusion success, pain relief, and device safety for up to two years. The goal is to gather real-world data on how these already-approved p…
Sponsor: Medtronic Spinal and Biologics • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC